Scholars@Duke
Kristin M. Schroeder

Kristin M. Schroeder

Associate Professor of Pediatrics
Pediatrics, Hematology-Oncology
kristin.schroeder@duke.edu
Box 102382, Durham, NC 27710
330 Trent Drive, Rm 390, Durham, NC 27710

Scholarly Works - Conferences

Abstract 18: Use of Patient Reported Outcomes to Assess Treatment Associated Toxicities for Pediatric Burkitt Lymphoma Patients in Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · December 1, 2025 AbstractPurpose:Despite their increasing use in clinical practice and research in high resource settings, the use of patient re ... Full text Cite

Abstract 5: Impact of Community Education Program for Retinoblastoma in Tanzania,

Conference Cancer Epidemiology, Biomarkers & Prevention · December 1, 2025 AbstractPurpose:Over 85% of the 400,000 new pediatric cancer diagnoses annually occur in low- and middle- income countries (LMI ... Full text Cite

Abstract 4: Evolving Pediatric Cancer Outcomes in Tanzania: A Nine-Year Retrospective Study

Conference Cancer Epidemiology, Biomarkers & Prevention · December 1, 2025 AbstractPurpose:Pediatric cancer survival rates show substantial global disparities, with the 5-year survival rate in Sub-Sahar ... Full text Cite

Abstract 40: The Quantitative Assessment of Caregiver Understanding in Pediatric Oncology

Conference Cancer Epidemiology, Biomarkers & Prevention · December 1, 2025 AbstractPurpose:The 60% disparity in childhood cancer survival between low- and middle-income countries (LMICs) and high-income ... Full text Cite

CTIM-01. OUTCOMES AND IMMUNE RESPONSES AFTER PEPTIDE VACCINATION TARGETING HUMAN CYTOMEGALOVIRUS ANTIGEN PP65 IN CHILDREN AND YOUNG ADULTS WITH RECURRENT HIGH-GRADE GLIOMA AND MEDULLOBLASTOMA: RESULTS OF A PHASE 1 TRIAL

Conference Neuro-Oncology · November 11, 2024 AbstractINTRODUCTIONThe human cytomegalovirus (CMV) antigen pp65 is ubiquitously expressed in high-grade glioma (HGG) and medulloblast ... Full text Cite

Cost Estimates of Brachytherapy Delivery in Northern Tanzania Using Time-Driven Activity Based Costing

Conference INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS · October 1, 2024 Link to item Cite

Outcomes and immune response after peptide vaccination targeting human cytomegalovirus antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma

Conference Journal of Clinical Oncology · January 1, 2024 Background: The human cytomegalovirus (CMV) antigen pp65 is ubiquitously expressed in high-grade glioma (HGG) and medulloblastoma but not in adjacent brain. The primary objective of this first-in-human phase I trial (NCT03299309) was to assess the safety a ... Full text Cite

Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

Conference Journal of Patient Reported Outcomes · December 1, 2023 Background: The pediatric patient-reported outcomes version of the common terminology criteria for adverse event measure was developed and validated for use in pediatric cancer clinical trials to better capture the symptom experiences through direct self-r ... Full text Cite

Development of an Evidence-Based Clinical Tool for Childhood Cancer Survivorship Care in Tanzania

Conference Blood · November 2, 2023 CONCLUSIONSThree in every four childhood cancer survivors experience late effects from treatment. As childhood cancer outcomes improve globally, it is important for providers to screen for these potential la ... Full text Cite

Analysis of Nutrition Status and Outcomes for Pediatric Patients with Burkitt Lymphoma Treated in Mwanza, Tanzania

Conference Blood · November 2, 2023 Introduction: Despite decades of improvement in outcomes for pediatric cancers in High-Income Countries (HICs), outcomes remain incredibly disparate as compared to those achieved in Low- and Middle-Income Countries (LMI ... Full text Cite

Abstract 51: Impacts of the COVID-19 Pandemic on Pediatric and Adolescent Cancer Care in Northern Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2023 AbstractPurpose: Low- and middle-income countries (LMICs) have an increasing burden of pediatric cancer cases over recent years. In 2020, the COVID-19 pandemic further strained healthcare systems, presenting ... Full text Cite

Abstract 54: Influence of Neuro Oncology Capacity Development on Diagnosis of Pediatric Primary CNS Tumors in Northern Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2023 AbstractPurpose: The diagnosis of CNS tumors requires a multidisciplinary team including oncologists, neurosurgeons, radiologists and pathologists. We review the impact of expanding diagnostic capacity on th ... Full text Cite

Abstract 33: Epidemiology, Diagnosis, and Outcomes of Pediatric Burkitt Lymphoma Patients Treated at Bugando Medical Centre in Mwanza, Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2023 AbstractPurpose: Despite the significant improvement in outcomes over the last few decades for the treatment of pediatric Burkitt lymphoma, outcomes in sub-Saharan Africa remain poor, with an approximately 5 ... Full text Cite

Abstract 32: Epidemiological Characteristics and Histopathologic Patterns Cranial-Spinal Tumours (CSTs) at Bugando Medical Centre (BMC) in the Lake Zone Region of Mwanza Tanzania in a Period of 8 Years

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2023 AbstractPurpose: To understand the epidemiological characteristics and histopathologic patterns cranial-spinal tumours (CSTs) at Bugando Medical Centre (BMC) in the lake zone region of Mwanza Tanzania Full text Cite

Abstract 75: Swahili Translation and Cultural Adaptation of the Cancer Stigma Scale (CASS) for Use in the Non-Patient Population in Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2023 AbstractPurpose: The Cataldo Cancer Stigma Scale (CASS) was developed to measure patient experienced stigma, and further modified for use in non-patient communities. The aim of this study was to adapt a Swah ... Full text Cite

Abstract 34: Evaluation of Potential Risk for Developing Treatment-Associated Late Effects Among Childhood Cancer Survivors in Northern Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · June 1, 2023 AbstractPurpose: Global advancement in pediatric cancer treatment has significantly increased survival rates for children with cancer. Childhood cancer survivors (CCS) now represent a growing population at r ... Full text Cite

EDUCATION NEEDS OF CAREGIVERS OF CHILDREN WITH CANCER IN TANZANIA

Conference PEDIATRIC BLOOD & CANCER · November 2022 Link to item Cite

COMMUNITY STIGMA TOWARDS CHILDREN WITH CANCER IN TANZANIA

Conference PEDIATRIC BLOOD & CANCER · November 2022 Link to item Cite

A Pilot Study to Measure Nutrition Status in Ugandan Pediatric Oncology Patients

Conference JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS · November 2022 Link to item Cite

Abstract 102: Breakpoints in Protocol Compliance and Their Influence on Outcomes for Children with Wilms Tumor in Northern Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · July 1, 2021 AbstractPurpose: Standardized treatment protocols for Wilms tumor have been developed for use in low- and middle-income countries (LMICs), but equivalent outcomes as high-income countries are not achieved ou ... Full text Cite

Abstract 112: Use of WhatsApp to Improve Medical Provider Communication for Children with Wilms Tumor in Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · July 1, 2021 AbstractPurpose: Due to the rapid expansion of mobile phone usage throughout the world, mobile health (mHealth) technologies offer an innovative strategy to overcome challenges of care coordination and limit ... Full text Cite

Abstract 101: The Tanzanian Pediatric Cancer Network: A Comprehensive Evaluation of the Incidence of Presenting Patients and Access to Pediatric Cancer Care in Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · July 1, 2021 AbstractPurpose: In sub-Saharan Africa, cancer treatment facilities are often scarce and centered in urban areas, which means many patients must travel long distances to reach cancer care. Still, little is k ... Full text Cite

Abstract 4: Impact of Immunohistochemistry on Diagnostic Accuracy for Pediatric Cancer in Tanzania

Conference Cancer Epidemiology, Biomarkers & Prevention · July 1, 2021 AbstractPurpose: The current study evaluates the impact of immunohistochemistry (IHC) on diagnostic accuracy for pediatric cancer in Tanzania, and identifies the most common biomarkers used for diagnostic di ... Full text Cite

EPCT-01. A NOVEL PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL

Conference Neuro-Oncology · June 1, 2021 AbstractIntroductionThe cytomegalovirus (CMV) antigen, pp65, is ubiquitously expressed in malignant glioma and medulloblastoma but not ... Full text Link to item Cite

LGG-08. TREATMENT OUTCOMES AND TOLERABILITY OF TRAMETINIB IN PROGRESSIVE CIRCUMSCRIBED LOW-GRADE GLIOMAS

Conference Neuro-Oncology · June 1, 2021 AbstractCircumscribed low-grade gliomas comprise roughly one-third of pediatric CNS tumors. Most of these tumors are caused by activating mutations in the mitogen-activated protein kinase (MAPK) pathway. Dru ... Full text Cite

CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL

Conference Neuro-Oncology · November 9, 2020 AbstractINTRODUCTIONThe cytomegalovirus (CMV) antigen, pp65, is ubiquitously expressed in malignant glioma and medulloblastoma but not ... Full text Open Access Link to item Cite

CTIM-21PEPTIDE VACCINE DIRECTED TO CMV PP65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL

Conference NEURO-ONCOLOGY · 2020 Abstract INTRODUCTION The cytomegalovirus (CMV) antigen, pp65, is ubiquitously expressed in malignant glioma and medulloblastoma but not in healthy brain. The objective of this Phase I trial (NCT03299309) was to assess the safety and feasibility of a novel ... Full text Link to item Cite

Impact of Capacity Development Program on Outcomes for Pediatric Hematologic Malignancies in Tanzania

Conference Blood · November 13, 2019 Background:Globally, over 400,000 children are diagnosed with cancer each year, with hematologic malignancies being the most common diagnosis. However, there is a 60% survival gap between high income and low to midd ... Full text Cite

Impact of a pilot patient navigator program on pediatric cancer outcomes in a low resource setting.

Conference Journal of Clinical Oncology · May 20, 2019 e18152 Background: Oncology patient navigation programs have been successfully implemented at hospitals throughout the U.S., enhancing the quality of canceer care. In low resource settings, the barriers to receiving cancer care a ... Full text Cite

Phase 1 Trial of Cobomarsen, an Inhibitor of Mir-155, in Cutaneous T Cell Lymphoma

Conference Blood · November 29, 2018 AbstractBackground:Cobomarsen (MRG-106) is an inhibitor of miR-155, a microRNA with a strong link to cutaneous T cell lymphoma (CTCL) pathogenesis. The goals of this first in ... Full text Cite